MKI67 and neoplasm: The number of Ki-67-positive proliferating tumor cells did not differ significantly between the alectinib- or combination-treated tumors derived from H2228 cells; however, there were significantly more TUNEL-positive apoptotic tumor cells in the combination-treated tumors (Fig. 5d).